FrancophonIA/ELRC3.0 huggingface dataset:
English: Septanest must not be used in patients who are allergic to articaine or similar local anaesthetics (known as amide-type local anaesthetics) or to any other ingredient of the medicine.
Slovenian: Zdravilo Septanest se ne sme uporabljati pri bolnikih, ki so alergični na artikain ali podobne lokalne anestetike (znane kot amidni lokalni anestetiki) ali na katero koli drugo sestavino zdravila.
English: Septanest is a local anaesthetic (a medicine for preventing pain and discomfort in a part of the body during medical procedures).
Slovenian: Zdravilo Septanest je lokalni anestetik (zdravilo za preprečevanje bolečine in neugodja v delu telesa med medicinskimi postopki).
English: After considering the available data on the use of Septanest, the Agency concluded that the SmPC should be harmonised.
Slovenian: Po pregledu razpoložljivih podatkov o uporabi zdravila Septanest je agencija zaključila, da je treba uskladiti povzetke glavnih značilnosti zdravila.
English: What is Septanest?
Slovenian: Kaj je zdravilo Septanest?
English: On 4 June 2018, Septodont, the company that markets Septanest, referred the matter to EMA in order to harmonise the marketing authorisations for Septanest in the EU.
Slovenian: Podjetje Septodont, ki trži zdravilo Septanest, je 4. junija 2018 zadevo napotilo na agencijo EMA, da bi se uskladila dovoljenja za promet s tem zdravilom v EU.
English: This is more likely at the start of treatment or if the doctor increases your dose.
Slovenian: To je bolj verjetno na začetku zdravljenja ali če vam zdravnik poveča odmerek.
English: Your doctor has decided which dose is best for you.
Slovenian: Vaš zdravnik se je odločil, kateri odmerek je za vas najprimernejši.
English: Follow your doctor's instructions and do not change the dose yourself.
Slovenian: Upoštevajte zdravnikova navodila in ne spreminjajte odmerka sami.
English: • Take with or without food
Slovenian: • Lahko jih jemljete s hrano ali brez nje.
English: Adults including the elderly
Slovenian: Odrasli, vključno s starejšimi bolniki
English: The shell does not break down but passes through your body.
Slovenian: Ovoj se ne razgradi, ampak prehaja skozi telo.
English: Take any remaining tablets and the container with you.
Slovenian: Preostale tablete in vsebnik vzemite s seboj.
English: Contact your doctor or nearest hospital casualty department immediately.
Slovenian: Takoj obiščite zdravnika ali najbližji bolnišnični nezgodni oddelek.
English: • if you are allergic to any of the tablet ingredients
Slovenian: • če ste alergični na katerokoli sestavino tablet;
English: If it is almost time for your next dose though, do not double the dose just carry on as before.
Slovenian: Če je skoraj čas za naslednji odmerek, odmerka ne podvojite, ampak jemljite tablete kot prej.
English: Tell your doctor if any of the above apply to you.
Slovenian: Obvestite zdravnika, če karkoli od zgoraj navedenega velja za vas.
English: Frequencies are defined as very common (≥1/10); common (>1/100 to <1/10); uncommon (>1/1000 to <1/100); rare (>1/10 000 to <1/1000); very rare (<1/10
Slovenian: Pogostost je opredeljena kot: zelo pogosti (≥ 1/10), pogosti (> 1/100 do < 1/10), občasni (> 1/1000 do < 1/100), redki (> 1/10.000 do < 1/1000), zelo redki (< 1/10.000).
English: • medicine containing Estrogen
Slovenian: • zdravila, ki vsebujejo estrogen;
English: It contains Doxazosin, which belongs to a group of medicines called alpha-blockers.
Slovenian: Vsebuje doksazosin, ki spada v skupino zdravil, imenovanih alfa-blokatorji.
English: • other medicine to lower blood pressure
Slovenian: • druga zdravila za znižanje krvnega tlaka;
English: In hypertensive patients both conditions are treated concomitantly.
Slovenian: Pri hipertenzivnih bolnikih obe bolezni zdravimo sočasno.
English: UK Tel: 00 44 1707 853000 Fax: 00 44 1707 650734
Slovenian: Združeno kraljestvo Tel: 00 44 1707 853000 Faks: 00 44 1707 650734
English: Tell your doctor if you are already taking any of the following:
Slovenian: Povejte zdravniku, če že jemljete katero koli izmed naslednjih zdravil:
English: If necessary, your doctor may increase this dose to the maximum of two tablets once a day.
Slovenian: Zdravnik po potrebi lahko poveča odmerek na največ dve tableti enkrat dnevno.
English: • Swallow the tablets whole with a full glass of water
Slovenian: • Tablete pogoltnite cele, s polnim kozarcem vode.
English: Your medicine is in the form of a ‘prolonged-release' tablet.
Slovenian: Vaše zdravilo je v obliki tablet s "podaljšanim sproščanjem".
English: Very rare effects seen in less than 1 in 10,000 patients include blood changes and an increase in blood and creatinine levels.
Slovenian: Med zelo redkimi neželenimi učinki, ki so jih opazili pri manj kot 1 bolniku od 10.000, so spremembe krvi in zvišanje ravni kreatinina v krvi.
English: They should be informed about the potential risk form injuries and measures of precaution to minimize orthostatic symptoms.
Slovenian: Treba jih je opozoriti na morebitno tveganje poškodb in obvestiti o ukrepih za zmanjševanje ortostatskih simptomov.
English: A dosage regime of 82mg/kg/day (8 times the human exposure) was associated with reduced foetal survival.
Slovenian: Odmerki 82 mg/kg/dan (8kratna izpostavljenost pri človeku) so bili povezani z zmanjšanim preživetjem fetusov.
English: • if you have kidney problems such as bladder stones, difficulty passing urine or suffer from frequent urine infections.
Slovenian: • če imate težave z ledvicami, kot so kamni v mehurju, težave pri uriniranju ali pogoste okužbe sečil.
English: Pharmacotherapeutic group: Alpha-adrenoceptor antagonists, ATC code: C02CA04
Slovenian: Farmakoterapevtska skupina: zaviralci alfa-adrenergičnih receptorjev, oznaka ATC: C02CA04
English: Nonsteroidal antirheumatics or estrogens may reduce the antihypertensive effect of doxazosin.
Slovenian: Nesteroidni antirevmatiki ali estrogeni lahko zmanjšajo antihipertenzivni učinek doksazosina.
English: Do not drive or operate machinery if you feel less alert while taking this medicine.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Ne vozite avtomobila ali upravljajte s stroji, če se med jemanjem tega zdravila počutite manj zbrani.
English: Pack sizes: 10, 20, 28, 30, 50, 56, 60, 90, 98, 100, 140 (10 x 14) tablets Calendar packs of 28 and 98
Slovenian: Velikosti pakiranj: 10, 20, 28, 30, 50, 56, 60, 90, 98, 100, 140 (10 x 14) tablet.
English: Must not be chewed, divided or crushed.
Slovenian: Ne smejo se žvečiti, prepoloviti ali zdrobiti.
English: Postural hypotension and in rare cases syncope may occur at the beginning of therapy, especially at very high doses but also when treatment is recommenced after a break.
Slovenian: Na začetku zdravljenja lahko pride do posturalne hipotenzije in v redkih primerih do sinkope, zlasti pri zelo velikih odmerkih, vendar tudi pri ponovnem zdravljenju po premoru.
English: • if you have liver problems
Slovenian: • če imate težave z jetri;
English: 10 prolonged-release tablets 20 prolonged-release tablets 28 prolonged-release tablets 30 prolonged-release tablets 50 prolonged-release tablets 56 prolonged-release tablets 60 prolonged-release tablets 90 prolonged-release tablets 98 prolonged-release tablets 100 prolonged-release tablets 140 prolonged-release tablets
Slovenian: 10 tablet s podaljšanim sproščanjem 20 tablet s podaljšanim sproščanjem 28 tablet s podaljšanim sproščanjem 30 tablet s podaljšanim sproščanjem 50 tablet s podaljšanim sproščanjem 56 tablet s podaljšanim sproščanjem 60 tablet s podaljšanim sproščanjem 90 tablet s podaljšanim sproščanjem 98 tablet s podaljšanim sproščanjem 100 tablet s podaljšanim sproščanjem 140 tablet s podaljšanim sproščanjem
English: Studies in lactating rats given a single oral dose of radioactive doxazosin gave an accumulation in breast milk with a maximum concentration of about 20 times greater than the maternal plasma concentration.
Slovenian: V študijah na doječih podganah, ki so jim dali enkratni peroralni odmerek radioaktivnega doksazosina, so ugotovili kopičenje v mleku, kjer je bila najvišja koncentracija približno 20-krat višja od koncentracije v plazmi matere.
English: Very rare: increase of serum creatinine.
Slovenian: Zelo redki: zvišane vrednosti kreatinina v serumu
English: They are available in PVC/PVDC/aluminium blisters packs of 28 tablets [10, 20, 30, 50, 56, 60, 90, 98, 100, 140 (10 x 14) tablets and in HDPE tablet containers of 100, 250 tablets].
Slovenian: Na voljo so v pretisnih omotih iz PVC/PVDC/aluminija z 28 tabletami [10, 20, 30, 50, 56, 60, 90, 98, 100 in 140 (10 x 14) tabletami ter v vsebnikih za tablete iz polietilena velike gostote (HDPE) s 100 in 250 tabletami].
English: • if you have or have had a blockage in your gut
Slovenian: • če imate ali ste imeli kakršno koli obliko zapore prebavil;
English: • if you have diabetes
Slovenian: • _ če imate sladkorno bolezen;
English: White, round, biconvex tablets with bossing “DL”
Slovenian: Bele, okrogle, bikonveksne tablete z reliefnim napisom "DL".
English: Doxazosin may influence plasma renin activity and urinary excretion of vanillylmandelic acid.
Slovenian: Doksazosin lahko vpliva na aktivnost renina v plazmi in izločanje vanilil-mandljeve kisline z urinom.
English: LIST OF THE NAMES, PHARMACEUTICAL FORM(S), STRENGTH(S) OF THE MEDICINAL PRODUCT(S), ROUTE(S) OF ADMINISTRATION, APPLICANT(S)/MARKETING AUTHORISATION HOLDER(S) IN THE MEMBER STATES
Slovenian: SEZNAM IMEN, FARMACEVTSKIH OBLIK, JAKOSTI ZDRAVILA, NAČINOV UPORABE ZDRAVILA, VLAGATELJEV, IMETNIKOV DOVOLJENJA ZA PROMET Z ZDRAVILOM V DRŽAVAH ČLANICAH
English: Doxagamma 4 mg prolonged release tablets and associated names is contraindicated during lactation as the medicinal product accumulates in the milk of lactating rats (see section 5.3) and there is no information about the excretion of the medicinal product into human breast milk.
Slovenian: Zdravilo Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena je med dojenjem kontraindicirano, ker se zdravilo kopiči v mleku doječih podgan (glejte poglavje 5.3), o izločanju zdravila v mleko pri človeku pa ni podatkov.
English: Caution is also recommended when doxazosin is administered concomitantly with medicinal products, which may influence hepatic metabolism (e.g. cimetidine).
Slovenian: Previdnost je priporočljiva tudi, kadar se doksazosin uporablja sočasno z zdravili, ki vplivajo na presnovo v jetrih (npr. cimetidin).
English: - The scope of the referral was to agree whether Doxagamma 4mg prolonged release tablets differ significantly with regards to the release profile from the originator product with potential for increased incidence of adverse events such as dizziness and hypotension, whether there were significant differences in performance of test batches in the single dose phase of studies 5208 and 1995 and whether the applicant has deviated from CHMP guidelines on the design of the bioequivalence studies, particularly in relation to the effect of food with concern regarding the adequate sensitivity of to detect a difference between products,
Slovenian: - Namen napotitve je bil doseči soglasje o tem, ali se zdravilo Doxagamma 4 mg tablete s podaljšanim sproščanjem, kar se tiče profila sproščanja, pomembno razlikuje od originatorjevega zdravila, in ali je možnost pojavov neželenih učinkov, kot so omotica in hipotenzija, morebiti povečana; nadalje ali so bile razlike v rezultatih iz študij 5208 in 1995 testnih serij pri enkratnem odmerjanju pomembne, ter končno ali se je vlagatelj oddaljil od smernic pri oblikovanju bioekvivalenčnih raziskav, zlasti kar se tiče učinka, ki bi ga lahko imela hrana na ustrezno občutljivost za zaznavanje razlik med zdraviloma.
English: The empty tablet will be passed out in your stools.
Slovenian: Prazno tableto boste izločili z blatom.
English: This medicinal product is authorised in the Member States of the EEA under the following names: [See Annex I - To be completed nationally]
Slovenian: Zdravilo je pridobilo dovoljenje za promet v državah članicah EGP pod naslednjimi imeni: [Izpolni država članica]
English: Children and adolescents: Doxagamma 4 mg prolonged release tablets and associated names are not recommended for patients under the age of 18 years.
Slovenian: Otroci in mladostniki: Uporaba zdravila Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena pri bolnikih, mlajših od 18 let, se ne priporoča.
English: • if you need a blood test as Doxagamma 4 mg prolonged release tablets and associated names can affect some test results.
Slovenian: •_ če potrebujete krvne preiskave, ker lahko zdravilo Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena vpliva na rezultate nekaterih preiskav.
English: • medicine containing Dopamine, Metaraminol, Methoxamine, Adrenaline (Epinephrine) cough and cold remedies as they may contain Ephedrine, Phenylephrine.
Slovenian: • zdravila, ki vsebujejo dopamin, metaraminol, metoksamin, adrenalin (epinefrin); zdravila proti kašlju in prehladu, ker lahko vsebujejo efedrin ali fenilefrin.
English: Doxazosin should be administered with caution in patients with the following acute heart diseases: Pulmonary oedema as a result of aortic or mitral stenosis, heart failure at high output, right sided heart failure as a result of pulmonary embolism or pericardiac effusion and left sided ventricular heart insufficiency with low filling pressure.
Slovenian: Doksazosin je treba uporabljati previdno pri bolnikih z naslednjimi akutnimi srčnimi boleznimi: pljučni edem, ki je posledica aortne ali mitralne stenoze, srčna odpoved pri velikem minutnem volumnu, desnostranska srčna odpoved, ki je posledica pljučne embolije ali perikardnega izliva, in levostranska ventrikularna srčna insufienca z nizkim tlakom polnjenja srca.
English: Doxazosin therapy in patients with hepatic impairment should be performed with caution (see section 4.4).
Slovenian: Pri zdravljenju bolnikov z jetrno okvaro z doksazosinom je treba biti previden (glejte poglavje 4.4).
English: Do not worry if sometimes you notice the tablet shell in your stools.
Slovenian: Če včasih v blatu opazite ovoj tablete, ne skrbite.
English: • if you have heart disease or a heart condition
Slovenian: • če imate srčno bolezen;
English: Like all medicines, Doxagamma 4 mg prolonged release tablets and associated names can cause side effects, although not everybody gets them.
Slovenian: Kot vsa zdravila lahko tudi zdravilo Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena povzroči neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
English: - Hypersensitivity to the active substance, other quinazolines (e.g. prazosin, terazosin), or to any of the excipients - Benign hyperplasia and concomitant congestion of the upper urinary tract, chronic urinary ract infections or bladder stones - Overflow bladder, anuria or progressive renal insufficiency - History of esophageal or gastrointestinal obstruction or decreased lumen diameter of the gastrointestinal tract.
Slovenian: - Preobčutljivost za zdravilno učinkovino, druge kinazoline (npr. prazosin, terazosin) ali katero koli pomožno snov; - benigna hiperplazija prostate in sočasna obstrukcija zgornjih sečil, kronična okužba sečil ali kamni v mehurju; - prelivna inkontinenca, anurija ali progresivna ledvična insufienca; - ezofagealna ali gastrointestinalna obstrukcija v anamnezi ali zmanjšan premer lumna prebavil; - dojenje.
English: • Do not chew, break or crush the tablets.
Slovenian: • Tablet ne žvečite, prepolovite ali zdrobite.
English: Your ‘modified release' tablets have been specially designed to slowly release the medicine from the tablet shell.
Slovenian: Tablete s "podaljšanim sproščanjem" so bile izdelane tako, da se zdravilo iz ovoja sprošča počasi.
English: • painkillers called non-steroidal anti-inflammatory medicine (NSAIDs) eg.
Slovenian: • zdravila proti bolečinam, imenovana protivnetna zdravila (nesteroidni antirevmatiki), npr.
English: • if you have taken medicine containing Doxazosin or a similar medicine eg.
Slovenian: • če ste vzeli zdravilo, ki vsebuje doksazosin ali podobno zdravilo, npr. prazosin, in ste imeli alergijsko reakcijo;
English: Unit dose 50 x 1
Slovenian: Posamezna pakiranja s 50 x 1 tableto.
English: The majority of the adverse reactions were transient The adverse reaction profile in clinical trials with patients with benign prostatic hyperplasia corresponded to the one seen in hypertension.
Slovenian: Profil neželenih učinkov v kliničnih preskušanjih pri bolnikih z benigno hiperplazijo prostate je bil podoben kot pri bolnikih s hipertenzijo.
English: 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One prolonged-release tablet contains 4 mg doxazosin (as mesilate).
Slovenian: 2 KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena tableta s podaljšanim sproščanjem vsebuje 4 mg doksazosina (v obliki mesilata).
English: Administration of Doxagamma 4 mg prolonged release tablets and associated names to patients with prostatic hyperplasia results in a significant improvement in urodynamics and symptoms as a result of a selective blockade of alpha-adrenoceptors located in the prostatic muscular stroma, capsule and bladder neck.
Slovenian: Uporaba zdravila Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena pri bolnikih s hiperplazijo prostate pomembno izboljša urodinamiko in simptome zaradi selektivnega blokiranja alfa-adrenergičnih receptorjev v mišični stromi prostate, kapsuli in vratu mehurja.
English: ASSOCIATED NAMES
Slovenian: SPROŠČANJEM IN POVEZANA IMENA
English: Doxagamma 4 mg prolonged release tablets and associated names tablets are white, round, biconvex tablets with bossing “DL”.
Slovenian: Zdravilo Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena so bele, okrogle, bikonveksne tablete z reliefnim napisom "DL".
English: The pharmacokinetic properties of doxazosin in Doxagamma 4 mg prolonged release tablets and associated names lead to a minor variation in plasma levels.
Slovenian: Farmakokinetične lastnosti doksazosina v zdravilu Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena so vzrok za manjše razlike pri koncentracijah v plazmi.
English: (E321), alpha-tocopherol, anhydrous colloidal silica, sodium stearyl fumarate, methacrylic acid copolymer and titanium dioxide (E171)
Slovenian: Pomožne snovi so makrogol, mikrokristalna celuloza, povidon, butilhidroksitoluen (E 321), alfa-tokoferol, koloidni brezvodni silicijev dioksid, natrijev stearilfumarat, kopolimer metakrilne kisline in titanov dioksid (E 171).
English: Musculoskeletal, connective tissue and bone disorders: Uncommon: muscular pain, arthralgia, muscle weakness
Slovenian: Bolezni mišično-skeletnega sistema, vezivnega tkiva in kosti: Občasni: bolečine v mišicah, artralgija, šibkost mišic
English: Doxagamma 4 mg prolonged release tablets and associated names should not be used during pregnancy unless clearly needed.
Slovenian: Zdravila Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena ne smete uporabljati med nosečnostjo, razen če je nujno potrebno.
English: Doxagamma 4 mg prolonged release tablets and associated names can be used as sole agent or in combination with another medicinal product e.g. a thiazide diuretic, beta-adrenoceptor blocking agent, calcium antagonist or an ACE-inhibitor.
Slovenian: Zdravilo Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena se lahko uporablja samostojno ali v kombinaciji z drugimi zdravili, npr. tiazidnimi diuretiki, blokatorji beta-adrenergičnih receptorjev, kalcijevimi antagonisti ali zaviralci ACE.
English: PVC/PVDC/aluminium blisters
Slovenian: Pretisni omoti iz PVC/PVDC/aluminija.
English: Prolonged-release tablet oral
Slovenian: Tableta s podaljšanim sproščanjem peroralno
English: Doxagamma 4 mg prolonged release tablets and associated names can also be given to men suffering from an enlarged prostate gland, as it can relax the muscles allowing urine to be passed more easily.
Slovenian: Zdravilo Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena se lahko daje tudi moškim s povečano prostato, ker sprošča mišice, kar olajša uriniranje.
English: Administration of Doxagamma 4 mg prolonged release tablets and associated names in hypertensive patients causes a clinically significant reduction in blood pressure as a result of a reduction in systemic vascular resistance.
Slovenian: Uporaba zdravila Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena pri hipertenzivnih bolnikih povzroča klinično pomembno znižanje krvnega tlaka zaradi zmanjšanja sistemskega žilnega upora.
English: After oral administration of therapeutic doses, doxazosin in Doxagamma 4 mg prolonged release tablets and associated names is well absorbed with peak blood levels gradually reached at 6 to 8 hours after dosing.
Slovenian: Po peroralnem jemanju terapevtskih odmerkov se doksazosin v zdravilu Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena dobro absorbira, najvišje koncentracije v plazmi pa so postopoma dosežene v 6 do 8 urah po odmerjanju.
English: Contains butylhydroxytoluene (E321)
Slovenian: SEZNAM POMOŽNIH SNOVI Vsebuje butilhidroksitoluen (E 321).
English: Uncommon effects, seen in more than 1 out of 1,000 patients but less than 1 in 100 patients, include swelling of the face and body, feeling faint, cold fingers and toes,, dizziness on standing, a racing or irregular heart beat, a slow heart beat, angina, severe chest pain, difficulty breathing, tremor, muscle stiffness, weakness or pain, pain or swelling of joints, change in appetite, hair loss, nose bleeds, cough, sore swollen throat, low blood potassium levels, feeling thirsty, gout, nightmares, loss of memory, mood changes, loss of bladder control or less frequent urge to pass urine, ringing in the ears and changes in taste.
Slovenian: Med občasnimi neželenimi učinki, ki so jih opazili pri več kot 1 bolniku od 1000, vendar manj kot 1 bolniku od 100, so otekanje obraza in telesa, omedlevica, mrzli prsti na rokah in nogah, vrtoglavica ob vstajanju, hitro ali neredno bitje srca, počasno bitje srca, angina, hude bolečine v prsnem košu, težave pri dihanju, tresenje, otrdelost ali šibkost mišic ali bolečine v mišicah, bolečine v sklepih ali otekanje sklepov, spremembe apetita, izguba las, krvavitve iz nosu, kašelj, boleče oteklo grlo, nizke ravni kalija v krvi, občutek žeje, protin, nočne more, izguba spomina, spremembe razpoloženja, izguba nadzora nad sečnim mehurjem ali manj pogosta potreba po uriniranju, zvenenje v ušesih in spremembe okušanja.
English: The usual starting dose is one Doxagamma 4 mg prolonged release tablets and associated names tablet once a day.
Slovenian: Običajni začetni odmerek je ena tableta zdravila Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena enkrat dnevno.
English: 3 PHARMACEUTICAL FORM Prolonged-release tablet
Slovenian: 3 FARMACEVTSKA OBLIKA Tableta s podaljšanim sproščanjem.
English: At steady-state, the relative bioavailability of doxazosin from Doxagamma 4 mg prolonged release tablets and associated names compared to immediate release form was 54% at the 4 mg dose and 59% at the 8 mg dose.
Slovenian: V stanju dinamičnega ravnovesja je relativna biološka uporabnost doksazosina v zdravilu Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena 54 % relativne biološke uporabnosti doksazosina v tabletah s takojšnjim sproščanjem, pri odmerku 8 mg pa 59 %.
English: The majority of patients are controlled on the initial dose of 4 mg Doxagamma 4 mg prolonged release tablets and associated names.
Slovenian: Pri večini bolnikov za nadzor bolezni zadostuje začetni odmerek 4 mg zdravila Doxagamma 4 mg tablete s podaljšanim sproščanjem in povezana imena.
English: Rare side effects, seen in more than 1 in 10,000 patients but less than 1 out of 1,000, include depression, feeling restless, pins and needles, an allergic rash, itchy red skin, stomach pain, diarrhoea, being sick, a hoarse voice, fainting, loss of consciousness, jaundice, liver changes, low blood sugar, impotence, persistent erection.
Slovenian: Med redkimi neželenimi učinki, ki so jih opazili pri več kot 1 bolniku od 10.000, vendar manj kot 1 bolniku od 1000, so depresija, nemir, mravljinčenje, alergijski izpuščaj, srbeča rdeča koža, bolečina v želodcu, driska, slabost, hripav glas, omedlevanje, izguba zavesti, zlatenica, spremembe v jetrih, nizek krvni sladkor, impotenca, vztrajna erekcija.